Endpoints News 生物医药· Max Bayer·· 2026-10-13AI 评分50
Asahi Kasei Therapeutics 近 10 亿美元收购的疱疹新疗法获 FDA 批准
Asahi Kasei lands approval for new HSV treatment
AI 导读
日本药企 Asahi Kasei Therapeutics 的疱疹治疗药物获 FDA 批准。该药是公司今年早些时候以近 10 亿美元交易收购所得。
正文
Japanese pharma Asahi Kasei Therapeutics has snagged FDA approval for a herpes treatment that it acquired early this year in an almost $1 billion deal.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news